Ergocalciferol Capsules,
NDC Package 60760-275-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ergocalciferol Capsules, is ergocalciferol Capsules are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia. Marketed by St. Mary's Medical Park Pharmacy, this product is identified by NDC 60760-275 and is authorized under FDA application ANDA204276.

Identification & Billing

NDC Package Code
60760-275-12
Package Description
12 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
60760-275
11-Digit Billing Format
60760027512
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
12 EA

Clinical Specifications

Proprietary Name
Ergocalciferol Capsules,
Dosage Form
-
Usage Information
Ergocalciferol Capsules are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Regulatory & Marketing

Labeler Name
St. Mary's Medical Park Pharmacy
FDA Application #
ANDA204276
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-17-2020
End Marketing Date
02-29-2024
Listing Expiration
02-29-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60760-275-12 identifies a specific commercial package of 12 capsule in 1 bottle, plastic of Ergocalciferol Capsules,, labeled by St. Mary's Medical Park Pharmacy. This product is billed for "EA" each discreet unit and contains an estimated amount of 12 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by St. Mary's Medical Park Pharmacy on February 17, 2020. The current certification is valid through February 29, 2024.

How is this St. Mary's Medical Park Pharmacy product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60760027512. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 12 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60760-275-12
11-Digit CMS (5-4-2)
60760-0275-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.